Summary
The European Parliament opposes a draft decision to authorize specific genetically modified maize products for food and feed, citing procedural concerns and health risks. 10 08.06.2016
Other
health
environment
agriculture, forestry and fisheries
Key points
- The authorization of complex genetically modified maize varieties intended for use in food and animal feed.
- The proposal includes various sub-combinations of genetic modification events such as Bt11, MIR162, MIR604, and GA21.
- Concerns regarding the health impact of glyphosate, which is used with these crops, following its classification as a probable carcinogen.
- Criticism of a decision-making process where Member States' committees failed to deliver an opinion.
Documents (PDFs)
MOTION FOR A RESOLUTION on the draft Commission implementing decision of XXXX authorising the placing on the market of products containing, consisting of, or produced from genetically modified maize Bt11 × MIR162 × MIR604 × GA21, and genetically modified maizes combining two or three of the events Bt11, MIR162, MIR604 and GA21, and repealing Decisions 2010/426/EU, 2011/893/EU, 2011/892/EU and 2011/894/EU
Products containing, consisting of, or produced from genetically modified maizes
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.